Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- CZK 113.51T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | CZK 215.7B | CZK 1,427.17 | 2.33% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | CZK 181.9B | CZK 2,624.37 | 1.19% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | CZK 110.2B | CZK 1,957.60 | 1.20% up | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | CZK 182.7B | CZK 2,798.62 | 0.93% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | CZK 191.4B | CZK 6,848.71 | 0.94% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | CZK 161.3B | CZK 1,157.84 | 0.79% up | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | CZK 100B | CZK 600.27 | 0.11% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | CZK 132B | CZK 6,598.39 | 0.98% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | CZK 204B | CZK 2,148.09 | 2.96% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | CZK 172.9B | CZK 1,028.62 | 1.76% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | CZK 101.2B | CZK 923.98 | 1.18% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | CZK 337.2B | CZK 1,731.19 | 1.35% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | CZK 105.5B | CZK 300.47 | 2.74% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | CZK 111.2B | CZK 638.86 | 3.14% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | CZK 132.7B | CZK 2,033.00 | 0.59% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | CZK 107.5B | CZK 1,119.92 | 1.46% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | CZK 146.8B | CZK 2,164.44 | 1.04% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | CZK 112.7B | CZK 1,349.55 | 0.53% up | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | CZK 216.4B | CZK 9,317.73 | 0.72% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | CZK 348.4B | CZK 5,427.10 | 1.38% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | CZK 167.5B | CZK 1,530.58 | 1.78% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | CZK 136.6B | CZK 966.35 | 1.07% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | CZK 117.6B | CZK 2,788.06 | 0.22% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | CZK 258.8B | CZK 1,336.31 | 2.69% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | CZK 88.6B | CZK 647.20 | 0.95% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | CZK 295.1B | CZK 590.48 | 2.71% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | CZK 591.3B | CZK 2,695.31 | 0.55% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | CZK 631.4B | CZK 871.38 | 1.21% up | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | CZK 156.8B | CZK 2,981.33 | 1.40% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | CZK 70.5B | CZK 363.41 | 1.43% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | CZK 168.7B | CZK 2,146.64 | 1.48% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | CZK 193.3B | CZK 241.75 | 1.87% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | CZK 163B | CZK 1,862.08 | 1.98% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | CZK 396.5B | CZK 6,044.16 | 0.21% up | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | CZK 545.3B | CZK 12,804.24 | 1.43% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | CZK 761.9B | CZK 1,875.09 | 0.99% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | CZK 459.6B | CZK 3,431.58 | 1.41% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | CZK 143.3B | CZK 3,527.66 | 0.57% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | CZK 167.5B | CZK 480.84 | 2.37% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | CZK 525.8B | CZK 458.60 | 0.83% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | CZK 277.8B | CZK 333.18 | 1.29% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | CZK 1.1T | CZK 946.33 | 0.16% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | CZK 3.58T | CZK 627.85 | 0.84% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | CZK 2.73T | CZK 1,336.54 | 2.05% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | CZK 877.3B | CZK 1,525.69 | 0.12% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | CZK 2.21T | CZK 21,352.79 | 0.24% up | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | CZK 3.02T | CZK 11,918.85 | 0.32% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | CZK 708.3B | CZK 1,148.72 | 0.60% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | CZK 1.03T | CZK 9,026.49 | 1.79% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | CZK 4.03T | CZK 2,324.01 | 0.21% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | CZK 7.69T | CZK 3,120.44 | 2.14% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | CZK 11.33T | CZK 6,411.18 | 1.55% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | CZK 129.6B | CZK 190.38 | 0.81% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | CZK 3.92T | CZK 888.73 | 1.82% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | CZK 27.69T | CZK 31,091.08 | 1.24% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | CZK 2.18T | CZK 1,089.89 | 0.48% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | CZK 14.75T | CZK 6,127.12 | 1.15% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | CZK 2.53T | CZK 1,054.64 | 0.23% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | CZK 6.58T | CZK 3,486.07 | 1.50% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | CZK 6.2T | CZK 3,996.71 | 1.41% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | CZK 1.52T | CZK 476.17 | 1.06% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2404 CZK).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of CZK 113.51T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.